- New plant to open within the next ten days in Etain, North East France.
- INEOS also announces that it has delivered on its ten day promise and has started French production of one million bottles of hand sanitiser a month at its Lavera site.
- Hand sanitisers are a critical weapon in the fight against the Corona virus and remain in short supply across the France and Europe.
- Sister plants are all now in full production in UK, Germany and France.
- The INEOS Board has had a daily call on the progress of building the plants.
- Sir Jim Ratcliffe, founder and chairman of INEOS says, “I am extremely proud of the INEOS team who have already built three production facilities in literally a few days, with a fourth following next week. I believe these hand sanitisers will play a key role in the fight against the Coronavirus and will help protect hospital front line staff who deserve all the help we can give them.”
The company has also announced that it has met its ten-day target to build a hand sanitiser plant in Lavera France and has today started production of 1 million hand sanitisers a month.
Hand to mouth contamination is one of the main ways that the Coronavirus infects people and there is a critical shortage of hand sanitisers across France and the rest of Europe.
INEOS is focusing on meeting the needs of front line medical and care services as well as making “pocket bottle” hand sanitisers available for people’s personal use. These will be produced to World Health Organisation (WHO) specifications.
Sir Jim Ratcliffe, founder and chairman of INEOS says, “Now that production of the INEOS hand sanitiser has started, we are working on the fastest way to get them to where they need to be. I am confident that within a few days our sanitiser will start to be seen in hospitals, surgeries and people’s homes”.
INEOS is the leading European producer of the two key raw materials needed for sanitisers – isopropyl alcohol (IPA) and ethanol, producing almost 1 million tonnes. The company is already running these plants flat out and have been diverting more of this product to essential medical use including in the new INEOS factories.
INEOS takes its corporate and social responsibilities extremely seriously. Its products are essential to the production of essential healthcare products from rubber gloves, to PVC saline drips, syringes, ventilators, medical tubing. Its products purify the public’s drinking water. It produces raw materials for soap, phenol for aspirin and paracetamol, and its acetonitrile is being used in pharmaceutical analysis essential in procedures necessary to find a vaccine.
Sir Jim Ratcliffe, founder and chairman of INEOS adds, “INEOS is a company with enormous resources and manufacturing skills. If we can find other ways to help in the Coronavirus battle, we are absolutely committed to playing our part”
For more information please go to our website: www.ineoshandgel.com
Greenergy invests in advanced biofuels project
The project will utilise pyrolysis and hydrotreating technologies to convert waste tyres into renewable drop-in advanced biofuels that can be used in diesel and petrol and qualify as development fu...
Ineos reschedules Antwerp olefins project
INEOS confirmed today that it is rescheduling its plans to build Project ONE in Antwerp, the largest investment in European chemistry in the past 25 years.
Borealis and TOMRA open state-of-the-art plant for post-consumer plastic waste sorting and advanced mechanical recycling in Lahnstein, Germany,
Demo plant sorts post-consumer plastic waste and will produce ready-for-market fully formulated polymer pellets. Brand owners and converters will be able to access material for qualification and ma...
Neste successfully completed its first industrial-scale processing run with liquefied waste plastic in Porvoo, Finland
Neste has a target to process annually over 1 million tons of waste plastic from 2030 onwards. The company plans to use liquefied plastic waste as a raw material at its fossil oil refinery to upgra...